Sorry, but retiring ‘comfortably’ on $100K is a myth for most people. Here’s why.
There are a lot of ifs involved in just being “okay” at that savings level too. Source link
‘History has been made.’ Why promises by Trump, GOP platform to defend crypto are a big deal for the industry.
In a move that could significantly impact the future of digital assets, the Republican Party has included language in its
‘I’ve always been the responsible one’: My mother wants to leave her entire estate to me — so I can take care of my younger brother. Is this foolish?
“What are the tax and financial implications of receiving an estate and then passing on a large percentage of it
The stock market’s breadth may have already peaked. Here’s why a 20% drawdown could follow.
A few large-cap tech companies continue to drive up the S&P 500, and one strategist believes a significant drawdown for
HilleVax’s stock craters after biotech says it’s scrapping a norovirus vaccine for infants after a failed trial
HilleVax Inc.’s stock cratered 89% early Monday, after the biotech said it would discontinue development of a vaccine against norovirus
As bitcoin keeps falling, an S&P 500 correction could be close behind
The recent weakness of bitcoin could signal an imminent correction of the S&P 500 in the summer, as the two
Oil prices move lower as Israel-Hamas cease-fire talks ease supply worries
Oil futures moved lower Monday, slipping after Hamas over the weekend gave its initial approval of a U.S.-backed proposal for
EV maker Lucid’s stock leaps after deliveries jump 70% in Q2
Lucid’s stock rallied Monday, after the electric-vehicle maker reported a big jump in deliveries in the second quarter. Source link
ServiceNow’s stock gets its only ‘sell’ call. Here’s what’s driving it.
Guggenheim says the monetization of generative AI “is not happening en masse and is not likely to materialize this year.”
Eli Lilly to pay $3.2 billion in cash to buy this biotech with an IBD treatment
Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash